Literature DB >> 11480912

Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.

K A Leppig1, C M Disteche.   

Abstract

Patients who carry a structural abnormality of the X chromosome are a fascinating group who have provided opportunities to evaluate genotype/phenotype correlation in relation to X chromosome content and inactivation. Turner syndrome (TS) is most commonly associated with a 45,X karyotype and presents with an array of phenotypes, the main ones being poor viability in utero, ovarian failure and infertility, short stature, lymphedema, and other congenital malformations but usually not mental retardation. In some TS patients the karyotype shows both a normal X and a structurally rearranged X chromosome. These structural abnormalities, which include deletions, duplications, inversions, translocations, and rings, are associated with chromosome breaks and significant imbalance of gene content of the X chromosome. However, such abnormalities are generally well tolerated because of the preferential inactivation of the abnormal X, which can restore, at least in part, a balanced genetic makeup. This beneficial effect of X inactivation results in a mild phenotype in most patients with structural abnormalities of the X, similar to that found in TS patients with a 45,X karyotype. However, in cases of ring X chromosomes and of X/autosome translocations the incidence of mental retardation and other congenital abnormalities can be significantly higher than in TS. These abnormal phenotypes can be ascribed to failed or partial X inactivation and/or incomplete selection in favor of cells with normal balance of gene expression. In this article, we present phenotype/genotype correlation in female patients with structural abnormalities of the X and address the role of X inactivation and cell selection in the phenotypic findings. Our review emphasizes a subset of rare patients with ring X chromosomes who have provided evidence of a direct role for X inactivation in determining phenotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11480912     DOI: 10.1055/s-2001-15395

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  18 in total

Review 1.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

Review 2.  X-marks the spot: X-chromosome identification during dosage compensation.

Authors:  Jessica Chery; Erica Larschan
Journal:  Biochim Biophys Acta       Date:  2014-01-07

Review 3.  Dosage compensation of the sex chromosomes.

Authors:  Christine M Disteche
Journal:  Annu Rev Genet       Date:  2012-09-04       Impact factor: 16.830

Review 4.  Possible fetal determinants of male infertility.

Authors:  Anders Juul; Kristian Almstrup; Anna-Maria Andersson; Tina K Jensen; Niels Jørgensen; Katharina M Main; Ewa Rajpert-De Meyts; Jorma Toppari; Niels E Skakkebæk
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

5.  Sex chromosome inactivation in the male.

Authors:  Wei Yan; John R McCarrey
Journal:  Epigenetics       Date:  2009-10-25       Impact factor: 4.528

6.  Aneuploidy as a mechanism for stress-induced liver adaptation.

Authors:  Andrew W Duncan; Amy E Hanlon Newell; Weimin Bi; Milton J Finegold; Susan B Olson; Arthur L Beaudet; Markus Grompe
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

Review 7.  X chromosome regulation: diverse patterns in development, tissues and disease.

Authors:  Xinxian Deng; Joel B Berletch; Di K Nguyen; Christine M Disteche
Journal:  Nat Rev Genet       Date:  2014-04-15       Impact factor: 53.242

8.  Molecular cytogenetic characterization of two Turner syndrome patients with mosaic ring X chromosome.

Authors:  Pooja Chauhan; Sushil Kumar Jaiswal; Anjali Rani Lakhotia; Amit Kumar Rai
Journal:  J Assist Reprod Genet       Date:  2016-07-07       Impact factor: 3.412

9.  Turner syndrome caused by rare complex structural abnormalities involving chromosome X.

Authors:  Niu Li; Li Zhao; Juan Li; Yu Ding; Yongnian Shen; Xiaodong Huang; Xiumin Wang; Jian Wang
Journal:  Exp Ther Med       Date:  2017-07-10       Impact factor: 2.447

Review 10.  Human X chromosome inactivation and reactivation: implications for cell reprogramming and disease.

Authors:  Irene Cantone; Amanda G Fisher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.